These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 11127916)

  • 1. Immunohistochemical detection of CD10 in paraffin sections of hematopoietic neoplasms: a comparison with flow cytometry detection in 56 cases.
    Chu PG; Chang KL; Weiss LM; Arber DA
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):257-62. PubMed ID: 11127916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of CD10 with monoclonal antibody 56C6 on paraffin sections.
    Kaufmann O; Flath B; Späth-Schwalbe E; Possinger K; Dietel M
    Am J Clin Pathol; 1999 Jan; 111(1):117-22. PubMed ID: 9894462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoperoxidase detection of CD10 in Precursor T-lymphoblastic lymphoma/leukemia: a clinicopathologic study of 24 cases.
    Conde-Sterling DA; Aguilera NS; Nandedkar MA; Abbondanzo SL
    Arch Pathol Lab Med; 2000 May; 124(5):704-8. PubMed ID: 10782151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10 expression in follicular lymphoma versus reactive follicular hyperplasia: evaluation in paraffin-embedded tissue.
    Barcus ME; Karageorge LS; Veloso YL; Kornstein MJ
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):263-6. PubMed ID: 11127917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
    Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
    Hanson CA; Ross CW; Schnitzer B
    Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
    de Leon ED; Alkan S; Huang JC; Hsi ED
    Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas.
    Eshoa C; Perkins S; Kampalath B; Shidham V; Juckett M; Chang CC
    Am J Clin Pathol; 2001 Jun; 115(6):862-7. PubMed ID: 11392883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry.
    Kurtin PJ; Hobday KS; Ziesmer S; Caron BL
    Am J Clin Pathol; 1999 Sep; 112(3):319-29. PubMed ID: 10478136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
    Chu P; Arber DA
    Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of multiparameter flow cytometry with cluster analysis and immunohistochemistry for the detection of CD10 in diffuse large B-Cell lymphomas.
    Xu Y; McKenna RW; Kroft SH
    Mod Pathol; 2002 Apr; 15(4):413-9. PubMed ID: 11950915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping of acute lymphoblastic leukemia using immunohistochemistry in bone marrow biopsy specimens.
    Al Gwaiz LA; Bassioni W
    Histol Histopathol; 2008 Oct; 23(10):1223-8. PubMed ID: 18712674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue.
    McIntosh GG; Lodge AJ; Watson P; Hall AG; Wood K; Anderson JJ; Angus B; Horne CH; Milton ID
    Am J Pathol; 1999 Jan; 154(1):77-82. PubMed ID: 9916921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma.
    Schniederjan SD; Li S; Saxe DF; Lechowicz MJ; Lee KL; Terry PD; Mann KP
    Am J Clin Pathol; 2010 May; 133(5):718-26. PubMed ID: 20395518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
    Rodig SJ; Abramson JS; Pinkus GS; Treon SP; Dorfman DM; Dong HY; Shipp MA; Kutok JL
    Clin Cancer Res; 2006 Dec; 12(23):7174-9. PubMed ID: 17145843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.